Baxter International

BAX No buying or selling

CIK 0000010456 #65 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

27 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hider Andrew P.

President and CEO

—

—

—

518,447

0.1003%

$21.05M

+17,971%

Grade Joel T.

EVP and CFO

—

—

—

271,674

0.0525%

$11.03M

+164.6%

ALMEIDA JOSE E

Chairman, CEO, President

—

—

—

243,589

0.0471%

$9.89M

−2.4%

Mason Jeanne K

EVP, Chief HR Officer

—

—

—

199,853

0.0387%

$8.12M

+4.8%

Knight Heather

EVP, Chief Operating Officer

—

—

—

177,362

0.0343%

$7.20M

+7.7%

Rosenbloom David S.

EVP and General Counsel

—

—

—

138,216

0.0267%

$5.61M

+22.6%

Sonig Alok

EVP,Group President,Pharma

—

—

—

128,219

0.0248%

$5.21M

+12.3%

Rasul Reazur

EVP,Group Pres,Healthcare

—

—

—

125,557

0.0243%

$5.10M

+10.3%

Toth Christopher A.

EVP, Group Pres, Kidney Care

—

—

—

105,186

0.0203%

$4.27M

−35.5%

Soriano Maria Cecilia

Group Pres., ITT & Pharma.

—

—

—

75,045

0.0145%

$3.05M

+37.3%

Shafer David Brent

Director

—

—

—

72,804

0.0141%

$2.96M

+384.8%

Borzi James W

EVP,Chief Supply Chain Officer

—

—

—

71,948

0.0139%

$2.92M

+5.2%

Wallace Steven P.

President, Adv. Surgery

—

—

—

70,128

0.0136%

$2.85M

−0.2%

Zielinski Anita A

SVP, Interim CFO, CAO & Cntrlr

—

—

—

59,714

0.0116%

$2.42M

+25,528%

Wendell Amy McBride

Director

—

—

—

44,235

0.0086%

$1.80M

+82.7%

MORRISON PATRICIA

Director

—

—

—

42,386

0.0082%

$1.72M

+89.5%

Wilkes David S.

Director

—

—

—

37,076

0.0072%

$1.51M

+117.4%

Oesterle Stephen N.

Director

—

—

—

35,847

0.0069%

$1.46M

+25.1%

SCHLICHTING NANCY M

Director

—

—

—

34,994

0.0068%

$1.42M

+133.7%

Ampofo William A. II

Director

—

—

—

30,375

0.0059%

$1.23M

+193.3%

Teaff James

President, CCS

—

—

—

30,370

0.0059%

$1.23M

−3.4%

Smith Cathy R

Director

—

—

—

30,345

0.0059%

$1.23M

+31.0%

Carlisle Cynthia

Executive Vice President, CHRO

—

—

—

29,677

0.0057%

$1.21M

—

Foster Julie

President, Front Line Care

—

—

—

29,164

0.0056%

$1.18M

−6.7%

Craig Jeffrey A

Director

—

—

—

23,662

0.0046%

$960.91K

+549.5%

RUSCKOWSKI STEPHEN H

Director

—

—

—

16,499

0.0032%

$670.02K

+77.1%

McDonnell Michael R.

Director

—

—

—

14,647

0.0028%

$594.81K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 33

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 666,861

History held since 30 Aug 2016